A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE3
This study is researching a drug called linvoseltamab (also called "study d...
2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
PHASE2
The Total Therapy treatment regimens developed at the Myeloma Institute hav...
Collection of Additional Data Followed the Study IFM 2013-04
N/A
Collection of retrospective additional data (survival, biological, disease ...
Status
Unknown
Location
Centre Hospitalier de la région d'Annecy
Start Date
2017-03-20
Trial ID
NCT03089411
A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
PHASE1
The objective of this study is to determine the maximum tolerated dose (MTD...